Reversal of diabetes in non-obese diabetic mice without spleen cell-derived beta cell regeneration
- PMID: 16556844
- DOI: 10.1126/science.1123510
Reversal of diabetes in non-obese diabetic mice without spleen cell-derived beta cell regeneration
Abstract
Autoimmune destruction of beta cells is the predominant cause of type 1 diabetes mellitus (T1DM) in humans and is modeled in non-obese diabetic (NOD) mice. Many therapeutic interventions prevent the development of T1DM in NOD mice, but few can induce its reversal once established. Intervention with Freund's complete adjuvant, semi-allogeneic splenocytes, and temporary islet transplantation has been reported to cure NOD mice of established T1DM. Using the same approach, we report here that this treatment cured 32% of NOD mice of established diabetes (>340 milligrams per deciliter blood glucose), although beta cells in these mice were not derived from donor splenocytes.
Comment in
-
Immunology. Diabetes studies conflict on power of spleen cells.Science. 2006 Mar 24;311(5768):1694. doi: 10.1126/science.311.5768.1694. Science. 2006. PMID: 16556811 No abstract available.
-
Comment on papers by Chong et al., Nishio et al., and Suri et al. on diabetes reversal in NOD mice.Science. 2006 Nov 24;314(5803):1243; author reply 1243. doi: 10.1126/science.1129918. Science. 2006. PMID: 17124308
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
